Comparison of different agents and doses of anti-vascular endothelial growth factors (aflibercept, bevacizumab, conbercept, ranibizumab) versus laser for retinopathy of prematurity: A network meta-analysis

  1. Ortiz-Seller, A.
  2. Martorell, P.
  3. Barranco, H.
  4. Pascual-Camps, I.
  5. Morcillo, E.
  6. Ortiz, J.L.
Journal:
Survey of Ophthalmology

ISSN: 1879-3304,  0039-6257

Year of publication: 2024

Volume: 69

Issue: 4

Pages: 585-605

Type: Review

DOI: 10.1016/J.SURVOPHTHAL.2024.02.005 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals

Data source: Scopus